Cargando…

Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer

BACKGROUND: Cancer/testis antigens (CTAs) participate in the regulation of malignant biological behaviors in breast cancer. However, the function and mechanism of KK-LC-1, a member of the CTA family, in breast cancer are still unclear. METHODS: Bioinformatic tools, immunohistochemistry, and western...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xudong, Bu, Jiawen, zhu, Tong, Jiang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996895/ https://www.ncbi.nlm.nih.gov/pubmed/36895039 http://dx.doi.org/10.1186/s12967-023-04030-9

Ejemplares similares

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

KK-LC-1 may be an effective prognostic biomarker for gastric cancer
por: Ji, Jun, et al.
Publicado: (2021)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas
por: Hsu, Robert, et al.
Publicado: (2021)

Study of a ($KK\pi$) enhancement in $KK3\pi$ annihilations
por: Armenteros, R, et al.
Publicado: (1966)

Implementation of KK for DELPHI (DElKK version 4.14/6)
por: Andringa, S, et al.
Publicado: (2003)

Elements of KK-theory
por: Jensen, Kjeld Knudsen, et al.
Publicado: (1991)

KK states and the radion
por: Randall, Lisa
Publicado: (2011)

Coupled-channel analysis of the pi eta and KK systems near KK threshold
por: Flatte, S M
Publicado: (1976)

The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer
por: Bian, Yanlin, et al.
Publicado: (2022)

Manumycin A inhibits triple-negative breast cancer growth through LC3-mediated cytoplasmic vacuolation death
por: Singha, P K, et al.
Publicado: (2013)

Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen
por: Futawatari, Nobue, et al.
Publicado: (2017)

Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
por: Bai, Rui, et al.
Publicado: (2022)

Mitochondrial Protein UCP1 Inhibits the Malignant Behaviors of Triple-negative Breast Cancer through Activation of Mitophagy and Pyroptosis
por: Xia, Jing, et al.
Publicado: (2022)

The Key Role of RNA Modification in Breast Cancer
por: Liu, Yang, et al.
Publicado: (2022)

$\phi$KK : real or artefact ?
por: Ferro-Luzzi, Massimiliano, et al.
Publicado: (1994)

Surprise, surprise: KK is innocent
por: Murzi, Julien, et al.
Publicado: (2021)

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
por: Wali, Vikram B., et al.
Publicado: (2019)

Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour
por: Fukuyama, Takashi, et al.
Publicado: (2018)

Development of adoptive immunotherapy with KK‐LC‐1‐specific TCR‐transduced γδT cells against lung cancer cells
por: Ichiki, Yoshinobu, et al.
Publicado: (2020)

Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma
por: Kang, Yanli, et al.
Publicado: (2022)

ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022)

Recent advances in targeted strategies for triple-negative breast cancer
por: Zhu, Shuangli, et al.
Publicado: (2023)

Zinc inhibits the reproductive toxicity of Zearalenone in immortalized murine ovarian granular KK-1 cells
por: Li, Yijia, et al.
Publicado: (2015)

Report on pp to KK at low momentum
por: Benvenuti, A C, et al.
Publicado: (1972)

KK Parity in Warped Extra Dimension
por: Agashe, Kaustubh, et al.
Publicado: (2007)

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
por: Inoue, Satoshi, et al.
Publicado: (2012)

NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism
por: Okada, Nobuhiro, et al.
Publicado: (2023)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer
por: Jin, Yi, et al.
Publicado: (2022)

LC-Q-TOF-MS Characterization of Polyphenols from White Bayberry Fruit and Its Antidiabetic Effect in KK-A(y) Mice
por: Liu, Yilong, et al.
Publicado: (2020)

MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors in vitro
por: Wang, Qi-Min, et al.
Publicado: (2019)

Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies
por: Ocana, Alberto, et al.
Publicado: (2017)

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer
por: Upreti, Meenakshi, et al.
Publicado: (2016)

Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
por: Shahi Thakuri, Pradip, et al.
Publicado: (2020)

Mario Lassnig in seinem "Labor" Foto: kk
Publicado: (2008)

ED SUM: Triple-negative breast cancer is inhibited by depleting mitochondrial copper in mice.: Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
por: Cui, Liyang, et al.
Publicado: (2020)

Triple-negative breast cancer and the potential for targeted therapy
por: Jhan, Jing-Ru, et al.
Publicado: (2017)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4iva01t1jdmtdjiqpc7s6c29os